Abstract
The evaluation of the activity of new drugs against small cell lung cancer (SCLC) is discussed and the results with gemcitabine are presented. Gemcitabine has activity against untreated SCLC. Preliminary results from an ongoing study also indicate activity in so-called resistant SCLC.
MeSH terms
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Carcinoma, Small Cell / drug therapy*
-
Deoxycytidine / analogs & derivatives*
-
Deoxycytidine / therapeutic use
-
Gemcitabine
-
Humans
-
Lung Neoplasms / drug therapy*
Substances
-
Antimetabolites, Antineoplastic
-
Deoxycytidine
-
Gemcitabine